Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults
- PMID: 27834597
- DOI: 10.3171/2016.8.JNS152875
Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults
Abstract
OBJECTIVE In this study the authors evaluated whether extracranial-intracranial bypass surgery can prevent stroke occurrence and decrease mortality in adult patients with symptomatic moyamoya disease (MMD). METHODS The medical records of 249 consecutive adult patients with symptomatic MMD that was confirmed by digital subtraction angiography between 2002 and 2011 at 8 institutions were retrospectively reviewed. The study outcomes of stroke recurrence as a primary event and death during the 6-year follow-up and perioperative complications within 30 days as secondary events were compared between the bypass and medical treatment groups. RESULTS The bypass group comprised 158 (63.5%) patients, and the medical treatment group comprised 91 (36.5%) patients. For 249 adult patients with MMD, bypass surgery showed an HR of 0.48 (95% CI 0.27-0.86, p = 0.014) for stroke recurrence calculated by Cox regression analysis. However, for the 153 patients with ischemic MMD, the HR of bypass surgery for stroke recurrence was 1.07 (95% CI 0.43-2.66, p = 0.887). For the 96 patients with hemorrhagic MMD, the multivariable adjusted HR of bypass surgery for stroke recurrence was 0.18 (95% CI 0.06-0.49, p = 0.001). For the treatment modality, indirect bypass and direct bypass (or combined bypass) did not show any significant difference for stroke recurrence, perioperative stroke, or mortality (log rank; p = 0.524, p = 0.828, and p = 0.616, respectively). CONCLUSIONS During the treatment of symptomatic MMD in adults, bypass surgery reduces stroke recurrence for the hemorrhagic type, but it does not do so for the ischemic type. The best choice of bypass methods in adult patients with MMD is uncertain. In adult ischemic MMD, a prospective randomized study to evaluate the effectiveness and safety of bypass surgery to prevent recurrent stroke is necessary.
Keywords: DSA = digital subtraction angiography; ECA = external carotid artery; EDAGS = encephalo-duro-arterio-galeo-synangiosis; EDAMS = encephalo-duro-arterio-myo-synangiosis; EDAS = encephalo-duro-arterio-synangiosis; EMS = encephalo-myo-synangiosis; ICA = internal carotid artery; JAM = Japanese Adult Moyamoya; MCA = middle cerebral artery; MMD = moyamoya disease; STA = superficial temporal artery; TIA = transient ischemic attack; adult; bypass surgery; hemorrhagic; ischemic; mRS = modified Rankin Scale; moyamoya disease; vascular disorders.
Similar articles
-
[Clinical efficacy of different vascular reconstruction on adult moyamoya disease].Zhonghua Yi Xue Za Zhi. 2019 Apr 2;99(13):998-1002. doi: 10.3760/cma.j.issn.0376-2491.2019.13.008. Zhonghua Yi Xue Za Zhi. 2019. PMID: 30955312 Chinese.
-
Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.J Neurosurg. 2020 Mar 13;134(3):909-916. doi: 10.3171/2019.12.JNS192938. Print 2021 Mar 1. J Neurosurg. 2020. PMID: 32168480
-
The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.World Neurosurg. 2015 May;83(5):691-9. doi: 10.1016/j.wneu.2015.01.016. Epub 2015 Feb 3. World Neurosurg. 2015. PMID: 25655688
-
Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.Rev Neurol (Paris). 2015 Jan;171(1):31-44. doi: 10.1016/j.neurol.2014.08.007. Epub 2014 Dec 30. Rev Neurol (Paris). 2015. PMID: 25555850 Review.
-
Indirect revascularization techniques for treating moyamoya disease.Neurosurg Clin N Am. 2010 Jul;21(3):553-63. doi: 10.1016/j.nec.2010.03.008. Neurosurg Clin N Am. 2010. PMID: 20561503 Review.
Cited by
-
Long-term mortality in patients with moyamoya angiopathy according to stroke presentation type in South Korea.Acta Neurochir (Wien). 2021 Dec;163(12):3473-3481. doi: 10.1007/s00701-021-04959-0. Epub 2021 Aug 24. Acta Neurochir (Wien). 2021. PMID: 34427768
-
Moyamoya syndrome with ruptured aneurysm in α-thalassemia: A case report.Exp Ther Med. 2022 Jul 5;24(3):556. doi: 10.3892/etm.2022.11494. eCollection 2022 Sep. Exp Ther Med. 2022. PMID: 35978939 Free PMC article.
-
Local transplantation of mesenchymal stem cells improves encephalo-myo-synangiosis-mediated collateral neovascularization in chronic brain ischemia.Stem Cell Res Ther. 2023 Sep 4;14(1):233. doi: 10.1186/s13287-023-03465-7. Stem Cell Res Ther. 2023. PMID: 37667370 Free PMC article.
-
Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients.Neurosurg Rev. 2022 Apr;45(2):1709-1720. doi: 10.1007/s10143-021-01689-w. Epub 2021 Dec 3. Neurosurg Rev. 2022. PMID: 34859335
-
Surgical Treatment of Adult Moyamoya Disease.Curr Treat Options Neurol. 2018 May 28;20(7):22. doi: 10.1007/s11940-018-0511-8. Curr Treat Options Neurol. 2018. PMID: 29808372 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous